HIMCH
VNDA icon

Hartford Investment Management Co (HIMCO)’s Vanda Pharmaceuticals VNDA Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,539
Closed -$275K – 683
2018
Q4 		$275K Hold
10,539
– – 0.01% 591
2018
Q3 		$242K Sell
10,539
-703
-6% -$14.4K 0.01% 677
2018
Q2 		$214K Buy
+11,242
New +$188K 0.01% 753

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s VNDA Position: Q1 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of Vanda Pharmaceuticals (VNDA) in Q1 2019, closing a stake of 10,539 shares — an estimated $275K sold.

Hartford Investment Management Co (HIMCO) first reported a position in VNDA in Q2 2018 and held it in 3 quarters. The position peaked at $275K in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q1 2019.

  • Hartford Investment Management Co (HIMCO) reported no remaining Vanda Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 10,539 Vanda Pharmaceuticals shares in Q1 2019, an estimated $275K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Vanda Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Hartford Investment Management Co (HIMCO)'s Vanda Pharmaceuticals position peaked at $275K in Q4 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q1 2019, filed 29 Apr 2019.